SCHEMBL24768615

SCHEMBL24768615

CCOC(=O)C(CC)c1cncc(Cl)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2C9 P11712 3/20 0.36
CYP3A4 P08684 1/20 0.36
KMT2A Q03164 2/20 0.36
CYP2C19 P33261 1/20 0.36
CTSA P10619 1/20 0.35
RAB9A P51151 1/20 0.35
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPK1 P28482 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
XBP1 P17861 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TLR9 Q9NR96 1/20 0.33
CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16419566 1.00 LMNA (0.36) LMNAALDH1A1MAPTTDP1CYP2C9
SCHEMBL30416055 0.88 CTSA (0.35) LMNAALDH1A1MAPTKMT2ACTSA
SCHEMBL22924871 0.88 CTSA (0.35) LMNAALDH1A1MAPTKMT2ACTSA
SCHEMBL21381662 0.85 CTSA (0.34) LMNAALDH1A1MAPTTDP1CYP2C9
SCHEMBL2580431 0.84 ALDH1A1 (0.38) LMNAALDH1A1MAPTTDP1CYP2C9
SCHEMBL16778254 0.83 ALDH1A1 (0.40) LMNAALDH1A1MAPTTDP1CYP2C9
SCHEMBL21381538 0.83 AKR1C3 (0.37) LMNAALDH1A1TDP1CYP2C9CYP3A4
SCHEMBL30556962 0.74 MAPK1 (0.39) LMNAALDH1A1MAPTKMT2ACTSA
SCHEMBL26122997 0.74 MAPK1 (0.39) LMNAALDH1A1MAPTKMT2ACTSA
SCHEMBL21381413 0.74 CTSA (0.43) LMNAALDH1A1MAPTCYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630515-B2 Small molecule prostagladin transport inhibitors ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2026-05-19 US disclosed
EP-4054608-B1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS ALBERT EINSTEIN COLLEGE MEDICINE (US) 2026-03-04 EP disclosed
US-20220402881-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS ALBERT EINSTEIN COLLEGE OF MEDICINE 2022-12-22 US disclosed
US-20220402881-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS ALBERT EINSTEIN COLLEGE OF MEDICINE 2022-12-22 US disclosed
EP-4054608-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS Albert Einstein College of Medicine (US) 2022-09-14 EP disclosed
US-20150031674-A1 SERINE/THREONINE KINASE INHIBITORS GENENTECH, INC. (US) 2015-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031674-A1 SERINE/THREONINE KINASE INHIBITORS PAK1, AKT1, RB1 LMNA 2523/4885ALDH1A1 2413/4885MAPT 1138/4885
US-20220402881-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS PTGER1, PTGIS, PTGIR LMNA 2850/4885ALDH1A1 875/4885MAPT 3079/4885
US-12630515-B2 Small molecule prostagladin transport inhibitors PTGER1, PTGS1, PTGIR LMNA 2813/4885ALDH1A1 1715/4885MAPT 4183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.